Evidence map›Paper›PMID 28176809›Full record

ArticleScientific reports2017

Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease.

Dirk Hubmacher, Michael Schneider, Steven J Berardinelli, Hideyuki Takeuchi, Belinda Willard, Dieter P Reinhardt, Robert S Haltiwanger, Suneel S Apte

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. A novel compound heterozygous mutation inInternational journal of ophthalmology · 2026
    Article
  4. An Overview of ADAMTS Proteases.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  5. Article
  6. Article
  7. ProteinMolecules (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Review
  10. Expression Profiling ofIranian journal of public health · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Novel homozygousInternational journal of ophthalmology · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. O-fucosylation of thrombospondin type 1 repeats is essential for ECM remodeling and signaling during bone development.Matrix biology : journal of the International Society for Matrix Biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Dirk HubmacherDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA.
Michael SchneiderDepartment of Biochemistry and Cell Biology, 450 Life Sciences Building, Stony Brook University, Stony Brook, NY 11794-5215, USA.
Steven J BerardinelliComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.
Hideyuki TakeuchiComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.
Belinda WillardMass Spectrometry Laboratory for Protein Sequencing, Lerner Research Institute, Cleveland Clinic, Cleveland, USA.
Dieter P ReinhardtDepartment of Anatomy and Cell Biology and Faculty of Dentistry, McGill University, Montreal, Quebec, H3A OC7, Canada.
Robert S HaltiwangerDepartment of Biochemistry and Cell Biology, 450 Life Sciences Building, Stony Brook University, Stony Brook, NY 11794-5215, USA.
Suneel S ApteDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA.
University of Georgia · USCleveland Clinic · USCleveland Clinic Lerner College of Medicine · USMcGill University · CAStony Brook University · US

Funding

O-Glycosylation of Epidermal Growth Factor-like MotifsR01GM061126 · NIGMS · UNIVERSITY OF GEORGIA · PI HALTIWANGER, ROBERT S. · 2001 to 2021
$9.1M
Zonule Assembly and Ectopia LentisR01EY021151 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI APTE, SUNEEL S · 2011 to 2015
$1.5M
LTQ-Orbitrap Velos instrumentS10RR031537 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2011 to 2011
$600k
CIHR MOP-106494NCRR NIH HHS S10 RR031537NEI NIH HHS R01 EY021151NIGMS NIH HHS R01 GM061126
6 · The paper itself

Abstract

Secreted metalloproteases have diverse roles in the formation, remodeling, and the destruction of extracellular matrix. Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs. Little is known about this protease or its connection to fibrillin microfibrils, whose major component, fibrillin-1, is genetically associated with ectopia lentis and alterations in height. Fibrillin microfibrils form the ocular zonule and are present in the drainage apparatus of the eye. We show that recombinant ADAMTS17 has unique characteristics and an unusual life cycle. It undergoes rapid autocatalytic processing in trans after its secretion from cells. Secretion of ADAMTS17 requires O-fucosylation and its autocatalytic activity does not depend on propeptide processing by furin. ADAMTS17 binds recombinant fibrillin-2 but not fibrillin-1 and does not cleave either. It colocalizes to fibrillin-1 containing microfibrils in cultured fibroblasts and suppresses fibrillin-2 (FBN2) incorporation in microfibrils, in part by transcriptional downregulation of Fbn2 mRNA expression. RNA in situ hybridization detected Adamts17 expression in specific structures in the eye, skeleton and other organs, where it may regulate the fibrillin isoform composition of microfibrils.

Indexed as

Protein Processing, Post-TranslationalADAMTS ProteinsAnimalsCells, CulturedFibrillin-1Fibrillin-2FucoseFurinHEK293 CellsHumansMiceMicrofibrilsProtein BindingRatsWeill-Marchesani SyndromeADAMTS17 protein, humanADAMTS ProteinsFibrillin-1Fibrillin-2FucoseFurin

Identifiers

PMID28176809
PMCPMC5296908
OpenAlexW2587304416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.